In the market taxonomy of Face Whitening Products, type-based segmentation delineates five formulation families that together capture the full product spectrum. Creams dominate with roughly 40 % of volume, owing to their occlusive base that facilitates prolonged melanin‑inhibitor contact and their compatibility with mass‑market retail channels. Serums account for about 25 %; their high‑concentration actives and lightweight carriers appeal to consumers prioritizing rapid absorption and visible results, often sold through specialty e‑commerce platforms. Lotions contribute near 15 %, offering a balance between hydration and whitening efficacy, which sustains demand in humid climates. Masks and sheet‑type treatments together hold approximately 12 %, driven by periodic intensive regimens and premium pricing that attract salon‑oriented buyers. Finally, oral formats such as tablets and gummies represent the remaining 8 %, reflecting a niche but growing segment where systemic antioxidants and glutathione are marketed for skin tone improvement. Each type imposes distinct regulatory, supply‑chain, and marketing considerations, collectively shaping the overall market size and competitive landscape for Face Whitening Products.